Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

The side effects of gonadotropin releasing hormone analog (diphereline) in treatment of idiopathic central precocious puberty.

Karamizadeh Z, Tabebordbar M, Saki F, Karamifar H, Amirhakimi G.

Acta Med Iran. 2013;51(1):41-6.

PMID:
23456583
[PubMed - indexed for MEDLINE]
Free Article
2.

[Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].

Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.

Orv Hetil. 2012 Mar 18;153(11):418-24. doi: 10.1556/OH.2012.29320. Hungarian.

PMID:
22390866
[PubMed - indexed for MEDLINE]
3.

Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.

Palmert MR, Mansfield MJ, Crowley WF Jr, Crigler JF Jr, Crawford JD, Boepple PA.

J Clin Endocrinol Metab. 1999 Dec;84(12):4480-8.

PMID:
10599706
[PubMed - indexed for MEDLINE]
4.

Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.

Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G.

Eur J Pediatr. 1998 May;157(5):363-7.

PMID:
9625331
[PubMed - indexed for MEDLINE]
5.
6.

Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.

Weise M, Flor A, Barnes KM, Cutler GB Jr, Baron J.

J Clin Endocrinol Metab. 2004 Jan;89(1):103-7.

PMID:
14715835
[PubMed - indexed for MEDLINE]
7.

Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers.

Arthur FK, Adu-Frimpong M, Osei-Yeboah J, Mensah FO, Owusu L.

Lipids Health Dis. 2012 Aug 10;11:101. doi: 10.1186/1476-511X-11-101.

PMID:
22883105
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.

Poomthavorn P, Suphasit R, Mahachoklertwattana P.

Gynecol Endocrinol. 2011 Aug;27(8):524-8. doi: 10.3109/09513590.2010.507289. Epub 2011 Apr 18.

PMID:
21501002
[PubMed - indexed for MEDLINE]
9.

Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.

Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, Bertelloni S.

Neuroendocrinology. 2009;89(4):441-7. doi: 10.1159/000197862. Epub 2009 Jan 29.

PMID:
19176945
[PubMed - indexed for MEDLINE]
10.

Combined therapy with GnRH analog plus growth hormone in central precocious puberty.

Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM.

J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:811-20.

PMID:
10969926
[PubMed - indexed for MEDLINE]
11.

[Metabolic syndrome in overweight and obese schoolchildren in Beijing].

Wan NJ, Mi J, Wang TY, Duan JL, Li M, Gong CX, Du JB, Zhao XY, Cheng H, Hou DQ, Wang L.

Zhonghua Er Ke Za Zhi. 2007 Jun;45(6):417-21. Chinese.

PMID:
17880785
[PubMed - indexed for MEDLINE]
12.

Influence of GnRH analog therapy on body mass in central precocious puberty.

Głab E, Barg E, Wikiera B, Grabowski M, Noczyńska A.

Pediatr Endocrinol Diabetes Metab. 2009;15(1):7-11.

PMID:
19454183
[PubMed - indexed for MEDLINE]
Free Article
13.

Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.

Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G.

Eur J Pediatr. 2000 May;159(5):369-74.

PMID:
10834524
[PubMed - indexed for MEDLINE]
14.

[Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].

Chen SK, Fan X, Tang Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 May;11(5):374-6. Chinese.

PMID:
19470261
[PubMed - indexed for MEDLINE]
15.

Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents.

Hobkirk JP, King RF, Gately P, Pemberton P, Smith A, Barth JH, Carroll S.

Metab Syndr Relat Disord. 2012 Feb;10(1):20-5. doi: 10.1089/met.2011.0050. Epub 2011 Sep 21.

PMID:
21936669
[PubMed - indexed for MEDLINE]
16.

Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.

Oostdijk W, Drop SL, Odink RJ, Hümmelink R, Partsch CJ, Sippell WG.

Acta Paediatr Scand Suppl. 1991;372:39-45; discussion 46.

PMID:
1833950
[PubMed - indexed for MEDLINE]
17.

Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.

Kapteijns-van Kordelaar S, Noordam K, Otten B, van den Bergh J.

Eur J Pediatr. 2003 Nov;162(11):776-80. Epub 2003 Sep 17.

PMID:
13680381
[PubMed - indexed for MEDLINE]
18.

Treatment with gonadotropin-releasing hormone analogues: different impact on body weight in normal-weight and overweight children.

Wolters B, Lass N, Reinehr T.

Horm Res Paediatr. 2012;78(5-6):304-11. doi: 10.1159/000346145. Epub 2012 Dec 21.

PMID:
23257624
[PubMed - indexed for MEDLINE]
19.

Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?

Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Trinavarat P.

J Med Assoc Thai. 2001 Jun;84 Suppl 1:S51-6.

PMID:
11529380
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk